Skip to main content
. 2022 Apr 26;18(6):2059–2073. doi: 10.1007/s12015-022-10378-0

Fig. 7.

Fig. 7

Immunohistochemical analysis after use of WNT pathway inhibitor (XAV939). WNT2b (A, C) and β-catenin (B, D) detected in wounds on the 14th day after use of WNT pathway inhibitor by immunohistochemical staining, Scale bar = 100 µm,200 μm. The data are the mean ± SD (n = 3; *p < 0.05, **p < 0.01)